medRxivGenetic & Genomic MedicinePreprint
Potential Misrepresentation of Inherited Breast Cancer Risk by Common Germline Alleles
William LetsouiD, Fan WangiD, Wonjong MooniD, Cindy ImiD, Yadav SapkotaiD, Leslie L. RobisoniD, Yutaka YasuiiD
Abstract
Hundreds of common variants have been found to confer small but significant differences in breast cancer risk, supporting the polygenic additive model of inherited risk. This widely accepted model is at odds with twin data indicating highly elevated risk in a subgroup of women. Using a novel closed-pattern-mining algorithm, we provide evidence that rare variants or haplotypes may underlie the association of breast cancer risk with common germline alleles. Our method, called Chromosome Overlap, consists in iteratively pairing chromosomes from affected individuals and looking for noncontiguous patterns of shared alleles without exhaustive enumeration. We applied Chromosome Overlap to haplotypes of genotyped SNPs from 9,011 female breast cancer cases from the UK Biobank (UKBB) at three topologically associating domains containing well-established common-allele "hits" for breast cancer. A total of 181,034 UKBB women of "white British" ancestry were used to assess the discovered haplotypes, and 55,346 cases and controls of European ancestry in the Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) case-control study were used for replication. Out of twenty rare (frequency < [~]0.1%) risk haplotypes of large effect identified in UKBB at P < 1.0 x 10-5, four (hazard ratio: 4.22-20.2) were subsequently replicated in DRIVE (odds ratio: 2.13-11.9) at P < 0.05. Our results support the genetic heterogeneity and rare-variant/haplotype basis of breast cancer risk and suggest a novel type of "synthetic association" wherein common risk alleles on a rare risk haplotype may misrepresent disease risk through their tagging of many "false positive" haplotypes. SignificanceChromosome Overlap reveals that common alleles identified by GWAS may be poor surrogates for underlying high-risk haplotypes, necessitating a reappraisal of the polygenic model of disease risk.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- research focus: benchmarking
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genome-wide Analysis of Rare Haplotypes Associated with Breast Cancer Risk: Discovery, Replication, and Generalizability Evaluation
Fan Wang, Wonjong Moon, … Yutaka Yasui·Cancer ResearchPeer-reviewed·Nov 9, 2022
- Segregation analysis of 17,425 population-based breast cancer families: evidence for genetic susceptibility and risk prediction
Shuai Li, Robert J. MacInnis, … Antonis C. Antoniou·The American Journal of Human GeneticsPeer-reviewed·Oct 1, 2022
- Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies
George Busby, Paul Craig, … Giordano Bottà·medRxiv·Aug 13, 2021
- Combining rare and common genetic variants improves population risk stratification for breast cancer
Alexandre Bolze, Daniel Kiser, … Joseph J. Grzymski·Genetics in Medicine OpenPeer-reviewed·Jan 1, 2024
- Familial heterogeneity in breast cancer predisposition: a study of 22 Utah families
Elizabeth O’Brien, Richard A. Kerber, Raymond L. White·bioRxiv·Dec 12, 2016
- Rare copy number variants (CNVs) and breast cancer risk
Joe Dennis, Jonathan P. Tyrer, … Rita Katharina Schmutzler·bioRxiv·May 20, 2021